We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gut “Memory” May Explain Why IBD Flares Return

By LabMedica International staff writers
Posted on 28 Aug 2026

Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, are characterized by recurring flare-ups that damage the intestinal mucosa and remain difficult to predict. More...

Although acute intestinal injury often precedes these conditions, the mechanisms that transform temporary damage into chronic inflammation are not fully understood. Clinicians also lack reliable markers to determine whether apparently healed tissue remains at risk. New findings show that lasting changes in the gut’s extracellular matrix can encode an inflammatory “memory” that alters stem cell fate long after symptoms have subsided.

Researchers at the Weizmann Institute of Science investigated whether short-lived intestinal inflammation leaves lasting imprints in the extracellular matrix (ECM), the protein-sugar scaffold surrounding epithelial cells. In mouse models of acute colitis, they tracked tissue architecture and ECM properties for more than a year after clinical recovery. The team also used miniature three-dimensional intestinal organoids grown from stem cells, along with single-cell RNA sequencing (scRNA-seq) resources and seven biopsies from patients with ulcerative colitis, to probe how ECM alterations influence epithelial differentiation.

The study identified collagen 18 as a key mediator of this inflammatory imprint. According to the authors, collagen 18 can trap signaling molecules within the ECM, disrupting pathways that normally direct stem cells to rebuild healthy epithelium and instead biasing them toward pro-inflammatory epithelial states. Silencing collagen 18 expression in mice prevented the ECM from sustaining irreversible damage and halted progression to chronic disease, supporting a causal role for ECM remodeling in persistent inflammation.

Even after the animals appeared to recover, the ECM remained less stiff, more porous, and disorganized at 80 and 400 days, revealing a long-lasting “memory” within the tissue microenvironment. Organoids grown on the disrupted ECM formed malformed sheets rather than normal crypt–villus structures, while transcriptomic profiling showed that the cells matured into inflammation-promoting epithelial states that recruit immune cells.

Published August 26, 2026, in Immunity, the findings suggest that the ECM acts as a “logistics hub” that stores and regulates signaling cues, with potential implications for predicting flare-prone regions and identifying therapeutic targets such as collagen 18.

“Growing stem cells as organoids within a disrupted extracellular matrix was enough to change their fate. Using a single-cell RNA sequencing database and seven biopsies from patients with ulcerative colitis, we found that these same pro-inflammatory epithelial cells also characterize inflamed regions in patients. These findings make it clear that the extracellular matrix plays a critical role in chronic inflammation and could potentially make it possible to predict which regions will develop inflammation or experience a future flare-up. More broadly, the new study reveals just how central the ECM is in creating a microenvironment, or niche, that supports stem cell regeneration,” said Dr. Moshe Biton of the Weizmann Institute of Science.

Related Links
Weizmann Institute of Science

 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Platelet Function Analyzer
PL-12
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Mpox Analysis Reveals Substantial Suspected False Positives Associated with Contamination

Reliable confirmation of mpox can be difficult where multiple rash-causing illnesses co-circulate and laboratory capacity is limited. Although PCR is central to case detection, contamination during specimen... Read more

Microbiology

view channel
Image: Ebola remains a rapidly evolving public health threat with high mortality, underscoring the need for timely diagnosis and decentralized testing closer to patients (Image Credit: Adobe Stock)

Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) and ReadyGo Diagnostics Ltd. (Bath, UK) have initiated a collaboration to evaluate ReadyGo’s GoCollect with the Co-Dx PCR platform for blood-based molecular... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.